Author:
Huh Jungwon,Mun Yeung Chul,Seong Chu Myong,Chung Wha Soon
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference13 articles.
1. Calabrese G, Fantasia D, Di Gianfilippo R, Stuppia L, Di Lorenzo R, Palka G (2006) Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia. Haematologica 91(7):994–995
2. Zagaria A, Anelli L, Albano F, Vicari L, Schiavone EM, Annunziata M, Pane F, Liso V, Rocchi M, Specchia G (2006) Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. Cancer Genet Cytogenet 167(2):97–102
3. Huh J, Moon H, Chung W (2008) A case of ABL deletion in a patient with precursor B cell lymphoblastic leukemia. Ann Hematol 87(3):239–241
4. Lo A, Gu G, Liu M, Dev VG (2009) ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia. Leuk Res 33(8):e98–e103
5. Kim MJ, Yoon HS, Lim G, Kim SY, Lee HJ, Suh JT, Lee J, Lee WI, Park TS (2010) ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review. Cancer Genet Cytogenet 196(2):184–188